back to US directory
us clinical guidance

Hemorrhoidal disease

ASCRS-based evaluation, bowel-habit treatment, office procedures, surgery selection and rectal-bleeding safety for symptomatic hemorrhoids.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Adults with symptomatic internal or external hemorrhoidal disease. The presence of hemorrhoids does not prove they are the source of rectal bleeding. Acute major hemorrhage, perirectal sepsis, inflammatory bowel disease, fissure, prolapse and suspected colorectal cancer require separate assessment.
sources for this section:ASCRS 2024

The Bottom Line

  • Take a disease-specific history and perform inspection, digital rectal examination and anoscopy when appropriate; identify bleeding, prolapse, pain, hygiene difficulty, thrombosis and bowel dysfunction rather than grading symptoms from a photograph alone.
  • Treat constipation, straining and prolonged time on the toilet with adequate fiber, fluids and behavior change as first-line therapy; these interventions reduce persistent symptoms and bleeding.
  • Offer office treatment to many patients with symptomatic grade I or II and selected grade III internal hemorrhoids after conservative care, with rubber-band ligation generally the most effective office procedure.
  • Consider excisional hemorrhoidectomy for selected patients with symptomatic combined internal and external disease or grade III鈥揑V prolapse, balancing greater effectiveness against pain and postoperative complications.
  • Do not routinely use stapled hemorrhoidopexy as first-line surgical treatment because it does not address external disease and carries a less favorable efficacy and risk profile than alternatives.
sources for this section:ASCRS 2024

Practical clinical workflow

1
Document stool consistency, frequency, straining, time on the toilet, prolapse reducibility, bleeding pattern, anticoagulants, prior colon evaluation and family history; examine the abdomen and anorectum appropriately.
2
Investigate rectal bleeding when no clear anorectal source is seen, symptoms persist after treatment, abdominal symptoms coexist or age and risk indicate colorectal evaluation.
3
Begin fiber supplementation and bowel-habit correction, manage constipation and use short-term symptom measures without promising that topical products cure prolapse.
4
For persistent internal symptoms, discuss banding, sclerotherapy or infrared coagulation with procedure-specific recurrence, pain and bleeding risks; coordinate antithrombotic decisions individually.
5
Refer for colorectal surgery when external disease, advanced prolapse, recurrent thrombosis, failed office care, diagnostic uncertainty or a need for operative treatment is present.
sources for this section:ASCRS 2024

Safety boundaries and escalation

  • Hemodynamic compromise, brisk ongoing bleeding, syncope, severe anemia or bleeding with systemic illness requires urgent evaluation rather than routine hemorrhoid treatment.
  • Severe pain with fever, urinary retention, spreading erythema or toxicity after an office or surgical procedure can signal sepsis or another serious complication and requires immediate review.
  • A painful lateral or multiple ulcer, mass, immunosuppression or atypical examination should prompt investigation for fissure, Crohn disease, infection or malignancy.
  • Anticoagulant and antiplatelet interruption can cause thrombosis while continuation can increase procedural bleeding; use the applicable indication-specific and procedural guidance rather than a blanket stop rule.
sources for this section:ASCRS 2024

Localization

ASCRS terminology and US procedural practice guide this page. Colorectal-cancer screening and diagnostic colonoscopy follow current US age and risk recommendations, while insurance coverage affects office and operative options.
sources for this section:ASCRS 2024

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. American Society of Colon and Rectal SurgeonsThe American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of HemorrhoidsDOI 10.1097/DCR.0000000000003276 路 published 2024-05-01 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.